Multimodal Study of the Human Brain Epilepsy Tissue

Not Applicable

Recruiting

• Conditions: Focal Drug-resistant Epilepsy
• Interventions: Other: Blood and tissue collection

• Registration Number: NCT06022055
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

The TIPI2 study is a blood and tissue collection protocol to create an annotated biorepository to support research in drug-resistant epilepsy.

The aim of the study will be to identify new pathophysiological pathways. For this purpose, the investigators will investigate with a multimodal approach blood and brain samples from patients undergoing a surgery for focal drug-resistant epilepsy. The adult patients will be enrolled either during the pre-surgical evaluation or right before the surgery.

Detailed Description

This study aims to investigate blood and brain samples from patients with drug-resistant epilepsy in order to identify new pathophysiological biomarkers.

The investigators will first conduct multimodal research, including:

* electrophysiological analyses

* immunohistochemistry and genetic studies

* biochemistry analyses

Samples will be stored at -80°C for future research.

Patients will undergo a follow-up evaluation within the 36 months following the surgery. New clinical data and biological samples will be collected then.

Study Timeline

• Study First Submitted: 2023-05-22
• Study First Submitted QC: 2023-08-30
• Study First Posted: 2023-09-01
• Study Start: 2024-02-29
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-04
• Last Update Posted: 2024-03-06
• Primary Completion: 2030-02-28
• Study Completion: 2037-02-28

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• 18 yo or above
• patients with a focal drug-resistant epilepsy
• patients hospitalized for a pre-surgical evaluation or for an epilepsy surgery
• consent obtained from the patient, or legally authorized representative
• affiliated to a social security system

Read More

Exclusion Criteria

• None

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
epileptic patients	Blood and tissue collection	All patients will be enrolled in the same arm. Patients can be enrolled during the pre-surgical evaluation (group 1) or in the days preceding the surgery (group 2).

Primary Outcome Measures

Name	Time	Method
Identification of new pathophysiological mechanisms leading to focal drug-resistant epilepsy : analysis by immuno-histological methods	At the day of surgery; analyses are based on the post-operative tissues	The investigator will identify inflammatory cells (astrocytes, microglia, lymphocytes and neutrophil polynuclear cells) in the post-operative brain tissue, and will calculate if there is an increase of a part of these cells in the area, defined as the seizure onset zone, as compared to the non-epileptic areas.
Identification of new pathophysiological mechanisms leading to focal drug-resistant epilepsy : analysis by electrophysiological methods	At the day of surgery; analyses are based on the post-operative tissues	The investigator will record local field potentials and neuronal firing rate from post-operative tissues, and we will research an increase of the rate of interictal epileptiform discharges and of the frequency of the neuronal firing in the seizure-onset zone, as compared to those in non-epileptic areas.
Identification of new pathophysiological mechanisms leading to focal drug-resistant epilepsy : analysis by RNA sequencing methods	At the day of surgery; analyses are based on the post-operative tissues	The investigator will measure the expression of mRNA in cells of different parts of the post-operative brain tissue, and we will research specific expression of mRNA in the Seizure onset zone, as compared to that in other non-epileptic areas.

Secondary Outcome Measures

Name	Time	Method
Identification of new pathophysiological mechanisms associated with an active epilepsy : analysis of biomarkers by ELISA methods	from inclusion day to 36 months after the surgery	The investigator will measure the different blood cells by flow cytometry, and we will define if there is a specific increase of some cell populations in the sample from epileptic patients, as compared to the level of these cell populations in non-epileptic patients.
Identification of new pathophysiological mechanisms associated with an active epilepsy : analysis of blood cell subtypes by flow cytometry	from inclusion day to 36 months after the surgery	The investigator will measure the different blood cells by flow cytometry, and we will define if there is a specific increase of some cell populations in the sample from epileptic patients, as compared to the level of these cell populations in non-epileptic patients.
Identification of new pathophysiological mechanisms associated with the occurrence of a seizure : analysis of biomarkers by ELISA methods	from inclusion day to 36 months after the surgery	The investigator will measure several proteins by Elisa, and we will define if there is a specific increase of some proteins in the sample after a seizure, as compared to the level of these proteins far from a seizure.
Identification of new pathophysiological mechanisms associated with an active epilepsy : analysis of inflammation biomarkers by digital ultra-sensitive quantitation of proteins methods	from inclusion day to 36 months after the surgery	The investigator will measure several inflammatory proteins including cytokines, and we will define if there is a specific increase of some proteins in the sample from epileptic patients, as compared to the level of these proteins in non-epileptic patients.

Trial Locations

Locations (1)

Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière Hospital; 🇫🇷 Paris, France